In this study, we investigated the detailed molecular signaling pathway triggered by KLC1-ROS1 fusion in glioma cells and discovered that JAK-STAT signaling was specifically activated in KLC1-ROS1 fusion-expressing human glioma cells. The gene discussed is KLC1; the disease is glioma.